3,4-dihydroxyphenylacetic acid has been researched along with Alloxan Diabetes in 15 studies
3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (40.00) | 18.7374 |
| 1990's | 8 (53.33) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saller, CF | 1 |
| Kamei, J | 3 |
| Saitoh, A | 3 |
| Iwamoto, Y | 1 |
| Funada, M | 1 |
| Suzuki, T | 1 |
| Misawa, M | 1 |
| Nagase, H | 1 |
| Kasuya, Y | 1 |
| Murzi, E | 1 |
| Contreras, Q | 1 |
| Teneud, L | 1 |
| Valecillos, B | 1 |
| Parada, MA | 1 |
| De Parada, MP | 1 |
| Hernandez, L | 1 |
| Ohtani, N | 1 |
| Ohta, M | 1 |
| Sugano, T | 1 |
| Carranza, A | 1 |
| Karabatas, L | 1 |
| Barontini, M | 1 |
| Armando, I | 1 |
| Bellush, LL | 2 |
| Henley, WN | 1 |
| Reid, SG | 1 |
| North, D | 1 |
| Shimomura, Y | 2 |
| Shimizu, H | 2 |
| Takahashi, M | 2 |
| Uehara, Y | 2 |
| Kobayashi, I | 2 |
| Kobayashi, S | 2 |
| Kwok, RP | 2 |
| Walls, EK | 1 |
| Juorio, AV | 2 |
| Gibson, CJ | 1 |
| Sato, N | 1 |
| Suwa, K | 1 |
| Tadokoro, S | 1 |
| Nishimura, C | 1 |
| Kuriyama, K | 1 |
15 other studies available for 3,4-dihydroxyphenylacetic acid and Alloxan Diabetes
| Article | Year |
|---|---|
Dopaminergic activity is reduced in diabetic rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Alloxan; Animals; Corpus Striatum; Diabetes Mellitus, Experimental; | 1984 |
Effects of diabetes on spontaneous locomotor activity in mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzazepines; Benzylidene Compounds; Brain; Corpus Striatum | 1994 |
Modification of the effects of 7-OH-DPAT, a dopamine D3-receptor agonist, on morphine-induced hyperlocomotion by diabetes.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Chromatography, High Pressure Liquid; Diabetes Mellitus, Ex | 1996 |
Diabetes decreases limbic extracellular dopamine in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Chromatography, High Pressure Liquid; Diabetes | 1996 |
Evidence for the modulation of spontaneous locomotor activity by higher serum glucose levels and/or spleen-derived factor(s) in diabetic mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Dopamine; G | 1997 |
Microdialysis study of modification of hypothalamic neurotransmitters in streptozotocin-diabetic rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Diabetes Mellitus, Experimental; Dopamine; gamma-Aminobutyr | 1997 |
Decreased tubular uptake of L-3,4-dihydroxyphenylalanine in streptozotocin-induced diabetic rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biological Transport; Diabetes Mellitus, Experimental; Dopa | 2001 |
Altered responses to environmental stress in streptozotocin-diabetic rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenal Medulla; Animals; Arousal; Blood Glucose; Body Temperature R | 1990 |
The functional significance of biochemical alterations in streptozotocin-induced diabetes.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Arousal; Brain; Brain Mapping; Corticosterone; Diabetes Mel | 1991 |
Ambulatory activity and dopamine turnover in streptozotocin-induced diabetic rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Diabetes Mellitus, Experimental; Dopamine; Light; Male; Mov | 1990 |
The concentration of dopamine, 5-hydroxytryptamine, and some of their acid metabolites in the brain of genetically diabetic rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Corpus Striatum; Diabetes Mellitus, Experimental; Do | 1985 |
Diurnal alterations in retinal tyrosine level and dopamine turnover in diabetic rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amino Acids; Animals; Circadian Rhythm; Diabetes Mellitus, Experimen | 1988 |
Changes in ambulatory activity and dopamine turnover in streptozotocin-induced diabetic rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Blood Glucose; Corpus Striatum; Diabetes Mellitus, Experime | 1988 |
Concentration of striatal tyramine and dopamine metabolism in diabetic rats and effect of insulin administration.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Blood Glucose; Corpus Striatum; Diabetes Mellitus, Experime | 1986 |
Alterations in the retinal dopaminergic neuronal system in rats with streptozotocin-induced diabetes.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Cattle; Diabetes Mellitus, Experimental; Diabetic Retinopat | 1985 |